SEC 13F Intelligence

Schroder Investment Management Group / LLY

Schroder Investment Management Group’s Eli Lilly & Co Position

Does Schroder Investment Management Group own Eli Lilly & Co (LLY)? Yes1.17M shares worth $1.1B (+0.88% of its 13F portfolio) as of Q1 2026, down from 1.95M shares the prior filed quarter.

Position Value
$1.1B
Q1 2026
Shares
1.17M
% of Portfolio
+0.88%
Quarters Held
29
currently held

Position History LLY

Reported value by quarter
Q1 ’19: $425MQ1 ’19Q2 ’19: $197MQ3 ’19: $218MQ4 ’19: $259MQ1 ’20: $266MQ1 ’20Q2 ’20: $279MQ3 ’20: $276MQ4 ’20: $741MQ1 ’21: $341MQ1 ’21Q2 ’21: $449MQ3 ’21: $389MQ4 ’21: $548MQ1 ’22: $579MQ1 ’22Q2 ’22: $603MQ3 ’22: $769MQ4 ’22: $834MQ1 ’23: $796MQ1 ’23Q2 ’23: $1.1BQ3 ’23: $1.2BQ4 ’23: $1.3BQ1 ’24: $1.6BQ1 ’24Q2 ’24: $1.7BQ3 ’24: $1.5BQ4 ’24: $1.3BQ1 ’25: $1.4BQ1 ’25Q2 ’25: $1.5BQ3 ’25: $1.4BQ4 ’25: $2.1BQ1 ’26: $1.1BQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.17M$1.1B+0.88%
Q4 20251.95M$2.1B+1.59%
Q3 20251.87M$1.4B+1.11%
Q2 20251.91M$1.5B+1.26%
Q1 20251.74M$1.4B+1.45%
Q4 20241.69M$1.3B+1.25%
Q3 20241.68M$1.5B+1.53%
Q2 20241.83M$1.7B+1.83%
Q1 20242.12M$1.6B+1.94%
Q4 20232.18M$1.3B+1.65%
Q3 20232.30M$1.2B+1.84%
Q2 20232.41M$1.1B+1.62%
Q1 20232.32M$796M+1.18%
Q4 20222.28M$834M+1.32%
Q3 20222.38M$769M+1.27%
Q2 20221.87M$603M+0.92%
Q1 20222.00M$579M+0.76%
Q4 20211.98M$548M+0.72%
Q3 20211.68M$389M+0.60%
Q2 20211.96M$449M+0.56%
Q1 20211.82M$341M+0.44%
Q4 20204.39M$741M+0.52%
Q3 20201.90M$276M+0.44%
Q2 20201.70M$279M+0.51%
Q1 20201.88M$266M+0.57%
Q4 20191.97M$259M+0.42%
Q3 20191.94M$218M+0.38%
Q2 20191.78M$197M+0.36%
Q1 20193.27M$425M+0.76%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Schroder Investment Management Group’s full portfolio or all institutional holders of LLY.